Results 161 to 170 of about 12,335 (206)

B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response. [PDF]

Clin Cancer Res
Mehta S, Ippagunta S, Varadharajan S, Kardian A, Laboe N, Dinh D, Jones AB, Meehl MM, Ibañez J, Emanus E, Dao T, Ward MB, Orisme W, Lange S, Langfitt D, Steinberg J, Chiang J, Vogel P, Sheppard H, Ellison DW, Mack SC, Krenciute G.   +21 more
europepmc   +1 more source

Promotion of the invasion and metastasis of breast cancer by B7-H3 through CCR5High tumor-associated macrophages. [PDF]

Cancer Cell Int
Dai T, Xu Z, Li Y, Wu M, Qiu Y, Chao Z, Jiang R, Chen Y, Lu L.   +8 more
europepmc   +1 more source

The investigational anti-B7-H3 antibody-drug conjugate vobramitamab duocarmazine exerts anti-tumor activity in vitro and in vivo in pediatric sarcoma preclinical models. [PDF]

Cell Death Dis
Bianchi G, Pastorino F, Rolandi G, Ciampi E, Segalerba D, De Giovanni B, Cafferata B, Balbi M, Ravera S, Vellone VG, Ponzoni M, Brignole C.   +11 more
europepmc   +1 more source

B7-H3-mediated reversal of CAR-T cell exhaustion induces a notable antitumour response in ovarian cancer models. [PDF]

EBioMedicine
Liu Q, Deng M, Jiang J, Tang F, Chang X, Yang R, Liu P, Zhang Y, Wu D, Kong W, Ma Q, He J, Miao J.   +12 more
europepmc   +1 more source

B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome [PDF]

core   +1 more source

Costimulatory and coinhibitory immune checkpoint receptors in head and neck cancer: unleashing immune responses through therapeutic combinations [PDF]

, 2016

core   +1 more source

Identification of c-Met on Tumor Cells as a Novel Receptor for B7-H3 Entails Implications for Cancer Cell Stemness and Targeted Therapy. [PDF]

MedComm (2020)
Cao L, Xu Y, Hu Y, Huang X, Fu F, Zhan S, Huang L, Feng Y, Irene Y, Li H, Markku V, Jorma KO, Zhang G, Lu B, Wang J, Liu W, Zhang X.   +16 more
europepmc   +1 more source

Engineered CXCR3-A expression enhances B7-H3-targeting CAR T cell migration and efficacy against diffuse intrinsic pontine glioma. [PDF]

Nat Commun
Song EZ, Timpanaro A, Meechan M, Elena-Sanchez L, Li LZ, Jamet S, Lau DS, Winter LI, Dun MD, Foster JB, Evans MK, Pattwell SS, Kalia V, Sarkar S, Jensen MC, Biery MC, Vitanza NA.   +16 more
europepmc   +1 more source

Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation. [PDF]

Cancer Immunol Immunother
De Maria R, Donini C, Capellero S, Massa A, Galvagno F, Proment A, Vitali L, Vigna E, Landoni E, Dotti G, Leuci V, Accornero P, Cesar Conti L, Olimpo M, Berrino E, Grignani G, Sapino A, Sangiolo D, Aresu L.   +18 more
europepmc   +1 more source

c-JUN enhances CRISPR knockin anti-B7-H3 CAR T cell function in small cell lung cancer and thoracic SMARCA4-deficient undifferentiated tumors. [PDF]

Cell Rep Med
Balke-Want H, Keerthi V, Del Carmen Arenas M, Chen Y, Malipatlolla M, Klysz DD, Xu P, Ho K, Asano K, Stahl D, Huang J, Retherford A, Patel S, Fowler C, Maas L, Gkitsas-Long N, Jiang Q, Liu X, Ullrich R, George J, Heitzeneder S, Tunuguntla R, Sage J, Sotillo E, Mackall CL, Feldman SA.   +25 more
europepmc   +1 more source